These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 26496594)

  • 1. Treatment for hypoactive sexual desire.
    Pfaus JG
    Cell; 2015 Oct; 163(3):533. PubMed ID: 26496594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of action of flibanserin, a multifunctional serotonin agonist and antagonist (MSAA), in hypoactive sexual desire disorder.
    Stahl SM
    CNS Spectr; 2015 Feb; 20(1):1-6. PubMed ID: 25659981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multifunctional pharmacology of flibanserin: possible mechanism of therapeutic action in hypoactive sexual desire disorder.
    Stahl SM; Sommer B; Allers KA
    J Sex Med; 2011 Jan; 8(1):15-27. PubMed ID: 20840530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Flibanserin as pharmacological therapy of inhibited sexual desire in women].
    Eldon AS; Giraldi A
    Ugeskr Laeger; 2017 Feb; 179(7):. PubMed ID: 28397671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flibanserin for female sexual dysfunction.
    Reviriego C
    Drugs Today (Barc); 2014 Aug; 50(8):549-56. PubMed ID: 25187905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flibanserin for hypoactive sexual desire disorder in premenopausal women.
    Clements JN; Thompson B
    JAAPA; 2018 Jun; 31(6):51-53. PubMed ID: 29846316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flibanserin: First Global Approval.
    Deeks ED
    Drugs; 2015 Oct; 75(15):1815-22. PubMed ID: 26412054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flibanserin for the treatment of hypoactive sexual desire disorder in premenopausal women.
    Dhanuka I; Simon JA
    Expert Opin Pharmacother; 2015; 16(16):2523-9. PubMed ID: 26395164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Weight Loss in Women Taking Flibanserin for Hypoactive Sexual Desire Disorder (HSDD): Insights Into Potential Mechanisms.
    Simon JA; Kingsberg SA; Goldstein I; Kim NN; Hakim B; Millheiser L
    Sex Med Rev; 2019 Oct; 7(4):575-586. PubMed ID: 31196764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flibanserin Efficacy and Safety in Premenopausal Women With Generalized Acquired Hypoactive Sexual Desire Disorder.
    Fisher WA; Pyke RE
    Sex Med Rev; 2017 Oct; 5(4):445-460. PubMed ID: 28666836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The abandonment of the development of flibanserin].
    Nau JY
    Rev Med Suisse; 2010 Oct; 6(268):2044-5. PubMed ID: 21137467
    [No Abstract]   [Full Text] [Related]  

  • 12. Understanding the Role of Serotonin in Female Hypoactive Sexual Desire Disorder and Treatment Options.
    Croft HA
    J Sex Med; 2017 Dec; 14(12):1575-1584. PubMed ID: 29198512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of flibanserin in postmenopausal women with hypoactive sexual desire disorder: results of the SNOWDROP trial.
    Simon JA; Kingsberg SA; Shumel B; Hanes V; Garcia M; Sand M
    Menopause; 2014 Jun; 21(6):633-40. PubMed ID: 24281236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting circuits of sexual desire as a treatment strategy for hypoactive sexual desire disorder.
    Stahl SM
    J Clin Psychiatry; 2010 Jul; 71(7):821-2. PubMed ID: 20667289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Addendum: Flibanserin (Addyi) for hypoactive sexual desire disorder.
    Med Lett Drugs Ther; 2015 Nov; 57(1481):156. PubMed ID: 26529137
    [No Abstract]   [Full Text] [Related]  

  • 16. Ex vivo binding of flibanserin to serotonin 5-HT1A and 5-HT2A receptors.
    Scandroglio A; Monferini E; Borsini F
    Pharmacol Res; 2001 Feb; 43(2):179-83. PubMed ID: 11243720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flibanserin: a potential treatment for Hypoactive Sexual Desire Disorder in premenopausal women.
    Clayton AH; Dennerstein L; Pyke R; Sand M
    Womens Health (Lond); 2010 Sep; 6(5):639-53. PubMed ID: 20887163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flibanserin (Addyi) for Hypoactive Sexual Desire Disorder in Premenopausal Women.
    Holt H; Tingen J
    Am Fam Physician; 2016 May; 93(10):826-8. PubMed ID: 27175717
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of Flibanserin Treatment on Body Weight in Premenopausal and Postmenopausal Women with Hypoactive Sexual Desire Disorder: A Post Hoc Analysis.
    Kornstein SG; Simon JA; Apfel SC; Yuan J; Barbour KA; Kissling R
    J Womens Health (Larchmt); 2017 Nov; 26(11):1161-1168. PubMed ID: 28817365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FDA Approval of Flibanserin--Treating Hypoactive Sexual Desire Disorder.
    Joffe HV; Chang C; Sewell C; Easley O; Nguyen C; Dunn S; Lehrfeld K; Lee L; Kim MJ; Slagle AF; Beitz J
    N Engl J Med; 2016 Jan; 374(2):101-4. PubMed ID: 26649985
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.